Cyclooxygenase-2 (COX-2) inhibitors were created in an attempt to minimize these side effects, although they show serious side effects of their own, such as prothrombotic state and increased risk of myocardial infarction and stroke [8,9]. This evidence concerns the gene PTGS2 and myocardial infarction.